-
EAU24 On-Site Highlights | Dr. Zedan Zhang of Professor Kan Gong’s Team on Perioperative Immunotherapy Strategies for MIBC
Radical cystectomy (RC) and pelvic lymph node dissection (PLND) are standard treatments for muscle-invasive bladder cancer (MIBC), yet distant metastasis remains a challenge for some patients. Exploring perioperative treatment options for MIBC is crucial to improve patient outcomes. At the 39th Annual European Association of Urology (EAU24) Congress in Paris, France, “Oncology Frontier” invited Dr.…
-
Dr. Ruiyi Deng of Professor Kan Gong’s Team on the Re-definition and Value of Small Renal Masses by the EAU Guidelines Panel
In recent years, numerous breakthroughs have been made in the field of renal tumors. The EAU Guidelines Panel continually incorporates new research data and evidence-based medicine to revise and update the EAU guidelines. At the 39th Annual European Association of Urology (EAU24) Congress held in Paris, France, “Oncology Frontier” invited Dr. Ruiyi Deng from Professor…
-
2024 Southern-Northern Summit丨Academician Binghe Xu : Progress and Future of Clinical Research in Breast Cancer
With the continuous development of medicine and science and technology, the field of breast cancer treatment has seen new breakthroughs. We have witnessed an increasing number of new discoveries and research advancements gradually being applied in clinical practice. These achievements not only enhance the efficiency of breast cancer diagnosis and treatment but also bring more…
-
Ultima Anastro de haute qualité aux États-Unis culturisme
Ultima Anastro de haute qualité aux États-Unis culturisme Le culturisme est un sport exigeant qui nécessite un engagement sérieux envers l’entraînement, la nutrition et les suppléments. Pour obtenir les meilleurs…
-
Professor Ming Zhao: Advances in the Use of Immunotherapy in Hepatocellular Carcinoma
Since the advent of immune checkpoint inhibitors (ICI) for the treatment of malignant tumors, the exploration of their use in hepatocellular carcinoma (HCC) has been relentless. In 2017 and 2018, nivolumab and pembrolizumab were respectively granted accelerated approval by the FDA for second-line treatment of HCC following progression on sorafenib. However, both agents failed to…
-
Professor Ming Zhao: Advances in the Use of Immunotherapy in Hepatocellular Carcinoma
Since the advent of immune checkpoint inhibitors (ICI) for the treatment of malignant tumors, the exploration of their use in hepatocellular carcinoma (HCC) has been relentless. In 2017 and 2018, nivolumab and pembrolizumab were respectively granted accelerated approval by the FDA for second-line treatment of HCC following progression on sorafenib. However, both agents failed to…
-
test
test test
-
Beneficios de Universal Animal Flex 44 bolsas curso
Beneficios de Universal Animal Flex 44 bolsas curso Universal Animal Flex 44 bolsas curso es un suplemento nutricional diseñado para ayudar a mantener las articulaciones sanas y flexibles. Este producto…
Connecting Medical Expertise through Media